"Our latest GPSDetect software uses our unique multi-sensor technology to provide surgeons unmatched guidance and accuracy," says Bram Schemers, CEO Sirius Medical. "Pintuition is highly intuitive and our TargetLOC™ feature provides additional visual feedback to the operator when the probe is perfectly aligned above the seed."
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
